CSA

At the recent Benzinga Cannabis Capital Conference in Chicago (Oct. 8 and 9), Emily Paxhia, founding partner and managing partner of Poseidon Investment Management, shared her thoughts on one of the most pressing legal battles facing the cannabis industry. Speaking shortly after her panel, Paxhia...

This article was originally published on Cannabis.net and appears here with permission. Rescheduling cannabis to a Schedule 3 drug may or may not be off the board with the Supreme Court ruling that overturned a 52-year-old decision on the Chevron Oil company. The cannabis industry was in a...

The Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) have proposed a groundbreaking change to the federal scheduling of marijuana, aiming to reclassify it from Schedule I to Schedule III of the Controlled Substances Act (CSA). This move, detailed in a formal notice of...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

Marijuana could end up being categorized as a Schedule III substance under the Controlled Substances Act (CSA), reported Marijuana Moment, citing a former top Food and Drug Administration (FDA) official. How? Howard Sklamberg, who chaired the FDA's Marijuana Working Group from 2014 to 2017,...

NASA and the Canadian Space Agency named the four astronauts who will be part of their Artemis II mission on Monday. What Happened: NASA astronauts Reid Wiseman, Victor Glover, and Christina Hammock Koch, and CSA astronaut Jeremy Hansen shall be part of the...

NASA and the Canadian Space Agency will reveal the names of the astronauts who will be part of their Artemis II mission on Monday. What Happened: NASA and the Canadian Space Agency shall reveal the names of the three NASA astronauts and the one CSA astronaut who will be part of the 10-day Artemis...

As voters head to the polls today to decide on marijuana legalization around the country among many other issues, the House Oversight Civil Rights and Civil Liberties Subcommittee announced that lawmakers will meet next week. The purpose of the hearing will be to discuss...

The ongoing battle led by palliative care specialist Dr. Sunil Aggarwal to pressure the DEA to allow end-of-life treatments for patients seeking to use psychedelics introduced another chapter.  The agency replied to Dr. Aggarwal’s petition last month stating that...

A new report warned that cannabis growers have no access to federal bankruptcy protection, thue 'undermining' the industry’s potential. This is because marijuana is still classified by federal law as an illicit substance. According to the Cannabis Law Journal, the fact that cannabis...

The most recent report for the Commerce, Justice, Science, and Related Agencies (CSJ) produced by the House of Committee on Appropriations includes a novel section concerning psilocybin, where it demands a Government Accountability Office (GAO) analysis concerning state, local and tribal psilocybin...

Despite Friday’s rebound, this was a bad week for the U.S. stock market. Cannabis stocks followed a very different trajectory, with the United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., posting a loss of 2.34 percent Friday, but still closing the week...